FTHFX | GCSCX | FTHFX / GCSCX | |
Total Expense Ratio | 0.63 | 1.95 | 32% |
Annual Report Gross Expense Ratio | 0.63 | 2.04 | 31% |
Fund Existence | 14 years | 28 years | - |
Gain YTD | 11.008 | 12.661 | 87% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 1000 | 100,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 11.3B | 528M | 2,140% |
Annual Yield % from dividends | 0.69 | 0.45 | 153% |
Returns for 1 year | 3.83 | -0.36 | -1,064% |
Returns for 3 years | 55.12 | 36.54 | 151% |
Returns for 5 years | 107.48 | 11.33 | 948% |
Returns for 10 years | 180.21 | 37.05 | 486% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
DDM | 108.91 | 1.05 | +0.97% |
ProShares Ultra Dow30 | |||
FTXH | 29.69 | 0.16 | +0.54% |
First Trust Nasdaq Pharmaceuticals ETF | |||
EMXF | 45.74 | 0.13 | +0.28% |
iShares ESG Advanced MSCI EM ETF | |||
XV | 26.74 | -0.01 | -0.04% |
Simplify Target 15 Distribution ETF | |||
SKYY | 135.06 | -0.74 | -0.54% |
First Trust Cloud Computing ETF |